L. Machiesky

发表

Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer

J. Hood, R. Wilkinson, N. Luheshi, 2021, mAbs.

ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome

Eric A. Wilson, P. Fromme, M. Borad, 2021, Science advances.

Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site

J. Carra, A. Soares, C. A. McHugh, 2007, BMC Structural Biology.

A rapid lateral flow immunoassay for identity testing of biotherapeutics.

LeeAnn Machiesky, Olivier Côté, Les H Kirkegaard, 2019, Journal of immunological methods.

Identification of an IgG CDR sequence contributing to co‐purification of the host cell protease cathepsin D

Li Peng, Hung-Yu Lin, Jared S. Bee, 2017, Biotechnology progress.

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

Weichen Xu, Y. Loo, N. Kallewaard, 2022, mAbs.

Monovalent IgG4 molecules

S. Fowler, D. Hayes, D. Corkill, 2013, mAbs.

A high yielding IFNAR1 ECD mammalian expression process for use in autoimmune disease drug development.

A. Hunter, Susan Wilson, S. Phipps, 2020, Protein expression and purification.

Development of a mechanism of action reflective and robust potency assay for a therapeutic antibody against alpha toxin using rabbit erythrocytes.

Zheng Wang, Weimin Chen, Shihua Lin, 2020, Journal of immunological methods.